Abstract
There have been significant advances in the management and treatment of lung cancer over the last 10–20 years, but surgical resection remains the primary treatment that results in cure and long-term survival. However, factors that predispose to the development of lung cancer also increase the incidence of chronic obstructive pulmonary disease. Physiological testing before lung cancer surgery is important, and every patient should undergo detailed lung function testing including measurement of the transfer factor for carbon dioxide (TLCO). Patients with a predicted postoperative FEV1 and TLCO of <40 % predicted should undergo cardiopulmonary exercise testing to further detail their risk status. Only in this way can a fully informed decision take place between the patient and surgeon as to the best treatment which not only attempts “cure” but also minimizes postoperative mortality while delivering acceptable postoperative breathlessness and quality of life. Age alone should never be used to deny surgery and function should be formally assessed as we have detailed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Young RP, Hopkins RJ. How the genetics of lung cancer may overlap with COPD. Respirology. 2011;16:1047–55.
Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81:265–84.
Rooney C, Sethi T. The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration. 2011;81:89–104.
Harris JM, Johnston ID, Rudd R, et al. Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. Thorax. 2010;65:70–6.
Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773–83.
Forrest LM, McMillan DC, McArdle CS, et al. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2005;93(9):977–8.
Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2:S94–100.
Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685–92.
Palma D, Visser O, Lagerwaard FJ, et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol. 2011;101:240–4.
Brunelli A, Charloux A, Bolliger CT, et al. European Sespiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34:17–41.
Brunelli A, Charloux A, Bolliger CT, European Respiratory Society, European Society of Thoracic Surgeons Joint Task Force on Fitness For Radical Therapy, et al. The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer. Eur J Cardiothorac Surg. 2009;36:181–4.
Lim E, Baldwin D, Beckles M, British Thoracic Society, Society for Cardiothoracic Surgery in Great Britain and Ireland, et al. Guidelines on the radical management of patients with lung cancer. Thorax. 2010;65 Suppl 3:iii1–27.
Goffin J, Lacchetti C, Ellis PM, Lung Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care, et al. First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review. J Thorac Oncol. 2010;5:260–74.
Greillier L, Thomas P, Loundou A, et al. Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer. Clin Lung Cancer. 2007;8:554–61.
Balduyck B, Hendriks J, Lauwers P, et al. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients. Lung Cancer. 2007;56:423–31.
Cerveri I, Dore R, Corsico A, et al. Assessment of emphysema in COPD: a functional and radiologic study. Chest. 2004;125:1714–8.
Kearney DJ, Lee TH, Reilly JJ, et al. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest. 1994;105:753–9.
Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):161S–77.
Win T, Jackson A, Sharples L, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J. 2005;25:594–9.
Pierce RJ, Copland JM, Sharpe K, et al. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med. 1994;150:947–55.
Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989;139:902–10.
Nakahara K, Monden Y, Ohno K, et al. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann Thorac Surg. 1985;39:260–5.
Nakahara K, Ohno K, Hashimoto J, et al. Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer. Ann Thorac Surg. 1988;46:549–52.
Brunelli A, Al Refai M, Monteverde M, et al. Predictors of early morbidity after major lung resection in patients with and without airflow limitation. Ann Thorac Surg. 2002;74:999–1003.
Varela G, Brunelli A, Rocco G, et al. Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy. Eur J Cardiothorac Surg. 2006;30:644–8.
Zeiher BG, Gross TJ, Kern JA, et al. Predicting postoperative pulmonary function in patients undergoing lung resection. Chest. 1995;108:68–72.
Schattenberg T, Muley T, Dienemann H, et al. Impact on pulmonary function after lobectomy in patients with chronic obstructive pulmonary disease. Thorac Cardiovasc Surg. 2007;55:500–4.
Baldi S, Ruffini E, Harari S, et al. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg. 2005;130:1616–22.
Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988;96:894–900.
Wang J, Olak J, Ferguson MK. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg. 1999;117:581–7.
Ferguson MK, Vigneswaran WT. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg. 2008;85:1158–65.
Williams AJ, Cayton RM, Harding LK, et al. Quantitative lung scintigrams and lung function in the selection of patients for pneumonectomy. Br J Dis Chest. 1984;78:105–12.
Olsen GN, Block AJ, Tobias JA. Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning. Chest. 1974;66:13–6.
Cordiner A, De Carlo F, De Gennaro R, et al. Prediction of postoperative pulmonary function following thoracic surgery for bronchial carcinoma. Angiology. 1991;42:985–9.
Bria WF, Kanarek DJ, Kazemi H. Prediction of postoperative pulmonary function following thoracic operations. Value of ventilation-perfusion scanning. J Thorac Cardiovasc Surg. 1983;86:186–92.
Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999;13:197–205.
Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993;6:5–40.
Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179–87.
Quanjer PH, Stocks J, Cole TJ, et al. Global lungs initiative. Influence of secular trends and sample size on reference equations for lung function tests. Eur Respir J. 2011;37:658–64.
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.
Brady LW, Germon PA, Cander L. The effects of radiation therapy on pulmonary function in carcinoma of the lung. Radiology. 1965;85:130–4.
Germon PA, Brady LW. Physiologic changes before and after radiation treatment for carcinoma of the lung. JAMA. 1968;206:809–14.
Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med. 1977;86:81–92.
Borst GR, De Jaeger K, Belderbos JS, et al. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys. 2005;2:639–44.
Gopal R, Starkschall G, Tucker SL, et al. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2003;56:114–20.
Leo F, Solli P, Spaggiari L, et al. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann Thorac Surg. 2004;77:260–5.
Takeda S, Funakoshi Y, Kadota Y, et al. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication? Ann Thorac Surg. 2006;82:232–6.
Cerfolio RJ, Talati A, Bryant AS. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications. Ann Thorac Surg. 2009;88:930–6.
Margaritora S, Cesario A, Cusumano G, et al. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery. J Thorac Cardiovasc Surg. 2010;139:1457–63.
Fishman A, Martinez F, Naunheim K, National Emphysema Treatment Trial Research Group, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–73.
National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001;345:1075–83.
Older P, Smith R, Courtney P, et al. Preoperative evaluation of cardiac-failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest. 1993;104:701–4.
Simpson JC, Sutton H, Grocott MPW. Cardiopulmonary exercise testing - a survey of current use in England. J Intensive Care Soc. 2009;10:275–8.
Ridgway ZA, Howell SJ. Cardiopulmonary exercise testing: a review of methods and applications in surgical patients. Eur J Anaesthesiol. 2010;27:858–65.
Snowden CP, Prentis JM, Anderson HL, et al. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Ann Surg. 2010;251:535–41.
Wilson RJ, Davies S, Yates D, et al. Impaired functional capacity is associated with all-cause mortality after major elective intra-abdominal surgery. Br J Anaesth. 2010;105:297–303.
American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–77.
Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 4th ed. Baltimore: Lippincott Williams & Wilkins; 2005.
Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest. 1999;116:355–62.
McCullough PA, Gallagher MJ, Dejong AT, et al. Cardiorespiratory fitness and short-term complications after bariatric surgery. Chest. 2006;130:517–25.
Carlisle J, Swart M. Mid-term survival after abdominal aortic aneurysm surgery predicted by cardiopulmonary exercise testing. Br J Surg. 2007;94:966–9.
Hopker JG, Jobson SA, Pandit JJ. Controversies in the physiological basis of the “anaerobic threshold” and their implications for clinical cardiopulmonary exercise testing. Anaesthesia. 2011;66:111–23.
Ozcelik O, Ward SA, Whipp BJ. Effect of altered body CO2 stores on pulmonary gas exchange dynamics during incremental exercise in humans. Exp Physiol. 1999;84:999–1011.
Wasserman K, Whipp BJ. Exercise physiology in health and disease. Am Rev Respir Dis. 1975;112:219–59.
Pollock ML, Foster C, Knapp D, et al. Effect of age and training on aerobic capacity and body composition of master athletes. J Appl Physiol. 1987;62:725–31.
Rogers MA, Hagberg JM, Martin WH, et al. Decline in VO2 Max with aging in master athletes and sedentary men. J Appl Physiol. 1990;68:2195–9.
Hossack KF, Bruce RA. Maximal cardiac function in sedentary normal men and women: comparison of age-related changes. J Appl Physiol. 1982;53:799–804.
Ogawa TR, Spina RJ, Martin WH, et al. Effects of aging, sex and physical training on cardiovascular responses to exercise. Circulation. 1992;86:494–503.
Sandvik L, Erikssen J, Thaulow E, et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med. 1993;328:533–7.
Toth MJ, Gardner AW, Ades PA, et al. Contribution of body composition and physical activity to age-related decline in peak VO2 in men and women. J Appl Physiol. 1994;77:647–52.
Posner JD, Gorman KM, Klein HS, et al. Ventilatory threshold: measurement and variation with age. J Appl Physiol. 1987;63:1519–25.
Smith TB, Stonell C, Purkayastha S, et al. Cardiopulmonary exercise testing as a risk assessment method in non cardio-pulmonary surgery: a systematic review. Anaesthesia. 2009;64:883–9.
West M, Jack S, Grocott MP. Perioperative cardiopulmonary exercise testing in the elderly. Best Pract Res Clin Anaesthesiol. 2011;25:427–37.
Hennis PJ, Meale PM, Grocott MPW. Cardiopulmonary exercise testing for the evaluation of perioperative risk in non-cardio-pulmonary surgery. Postgrad Med J. 2011;87:550–7.
Epstein SK, Faling J, Daly BDT, et al. Inability to perform bicycle ergometry predicts increased morbidity and mortality after lung resection. Chest. 1995;107:311–6.
Smith TP, Kinasewitz GT, Tucker WY, et al. Exercise capacity as a predictor of post-thoracotomy morbidity. Am Rev Respir Dis. 1984;129:730–4.
Colman NC, Schraufnagel DE, Rivington RN, et al. Exercise testing in evaluation of patients for lung resection. Am Rev Respir Dis. 1982;125:604–6.
Ussetti P, Roca J, Agusti AGN, et al. Failure of exercise tolerance and hemodynamic studies t predict early post-thoracotomy morbidity and mortality. Am Rev Respir Dis. 1988; A94.
Bechard D, Wetstein L. Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg. 1987;44:344–9.
Gerson MC, Hurst JM, Hertzberg VS, et al. Prediction of cardiac and pulmonary complications related to elective abdomen and non-cardiac thoracic surgery in geriatric patients. Am J Med. 1990;88:101–7.
Epstein SK, Faling LJ, Daly BD, et al. Predicting complications after pulmonary resection. Preoperative exercise testing vs. a multifactorial cardiopulmonary risk index. Chest. 1993;104:694–700.
Richter Larsen K, Svendsen UG, et al. Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma. Eur Respir J. 1997;10:1559–65.
Brutsche MH, Spiliopoulos A, Bolliger CT, et al. Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J. 2000;15:828–32.
Villani F, Busia A. Preoperative evaluation of patients submitted to pneumonectomy for lung carcinoma: role of exercise testing. Tumori. 2004;90:405–9.
Nagamatsu Y, Shima I, Hayashi A, et al. Preoperative spirometry versus expired gas analysis during exercise testing as predictors of cardiopulmonary complications after lung resection. Surg Today. 2004;34:107–10.
Win T, Jackson A, Sharples L, et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest. 2005;127:1159–65.
Bolliger CT, Jordan P, Soler M, et al. Exercise capacity as a predictor of post-operative complications in lung resection candidates. Am J Respir Crit Care Med. 1995;151:1472–80.
Benzo R, Kelley GA, Recchi L, et al. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med. 2007;101:1790–7.
Tilburg PMB, Stam H, Hoogsteden HC. Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature. Eur Respir J. 2009;33:1206–15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Walker, P.P., West, M., Grocott, M.P.W., Jack, S. (2013). Physiological Assessment and Cardiopulmonary Exercise Testing. In: Gridelli, C., Audisio, R. (eds) Management of Lung Cancer in Older People. Springer, London. https://doi.org/10.1007/978-0-85729-793-8_3
Download citation
DOI: https://doi.org/10.1007/978-0-85729-793-8_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-792-1
Online ISBN: 978-0-85729-793-8
eBook Packages: MedicineMedicine (R0)